ICON plc
This role involves leading a dynamic team to advance bioanalysis for small molecules, biomarkers, peptides, oligonucleotides, siRNAs, and antibody-drug conjugates using cutting-edge LC-MS/MS platforms and automated sample prep workflows.
ICON plc is a global clinical research organisation (CRO) that provides outsourced clinical development and commercialisation services to pharmaceutical, biotechnology and medical device companies. It offers end-to-end drug and device development support — including clinical trial management across phases, data management and biostatistics, regulatory and safety/pharmacovigilance, and commercialisation and market-access services. ICON combines scientific and therapeutic expertise with technology and a scalable global operations network to accelerate development and bring therapies to patients. Clients engage ICON for integrated, experienced CRO support across the full product lifecycle.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ICON plc.
45% above the average for this role
Principal Research Scientist – LC-MS/MS Bioanalysis
rpm research
Scientist in Large Molecule Bioanalysis
Neurocrine Biosciences
Bioanalytical Scientist
Cogent Biosciences
Scientist - LC-MS/MS Bioanalytical
Amgen
Scientist - LC-MS Bioanalytical
Amgen
Bench Scientist New Modalities (all genders)
City of Duncan, Oklahoma